GW Pharma has enjoyed recent success with its cannabinoid extract product Sativex (nabiximols), which is now approved in the UK and Spain as an add-on therapy for spasticity in multiple sclerosis, making it the first authorised cannabis-derived drug ...
Actelion this week acquired the option to buy private company Trophos, with the final decision dependent on the success of the French firm's lead product olesoxime, which is in Phase III development for amyotrophic lateral sclerosis. Trophos's CEO ...
Croatia's HZZO main responsibilities include setting drug prices, selecting reimbursable products and reimbursement. The institute uses France, Italy and Slovenia as reference countries for setting maximum wholesale prices, and the Czech Republic ...
The Icelandic Medicines Agency (IMA), which will mark its tenth anniversary on 1 November, is facing an uncertain future.
Plans by the IMA to take on more staff and play an even greater role in the European network of medicines agencies, for ...
